Market Research Report

Global Cellular Immunotherapy Market Report By Therapy Type (CAR T Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy, TIL Therapy, Others), By Indication (B-cell Malignancies, Prostate Cancer, Liver Cancer, Renal Cell Carcinoma, Others), By End-use (Hospitals, Cancer Institutes, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

ID:VMR11219156
September 2022
Report Formats: Electronic (PDF), MS EXCEL
The global demand for Cellular Immunotherapy Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.

Cellular immunotherapy is defined as an innovative cancer treatment approach that uses the cells of our immune system to eliminate cancer. Cellular immunotherapy approaches involve directly isolating immune cells & simply multiplying their numbers, whereas others involve genetically engineered immune cells through gene therapy to enhance their tumor-destroying capabilities. Cellular immunotherapy is widely preferred over old treatment because it provides long-term cancer protection, has lesser side effects, and has been successful in treating different cancers such as breast cancer, prostate cancer, melanoma, lung cancer, and many others. Cellular immunotherapy is performed by directing the immune cells toward cancer-specific targets, activating the immune system to assemble at the target, and triggering an immune response capable of destroying myeloma cells. 

Market Dynamics 

This robust growth of the cellular immunotherapy market is driven by several factors such as increasing acceptance of immunotherapy over conventional therapies, growing emergence of biosimilars, increasing demand for monoclonal antibodies (mAbs), and rising prevalence of cancer among a growing population. The market for cellular immunotherapy will increase due to the increased survival rate of patients who choose it as an alternative treatment option. Other factors propelling the market growth of cellular immunotherapy are an increase in healthcare spending, Increasing R&D activities, easy access to medical insurance, and a surge in technological advancements in cancer treatment methods.

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cellular immunotherapy. The growth and trends of cellular immunotherapy industry provide a holistic approach to this study. 

Market Segmentation

This section of the cellular immunotherapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Therapy Type
  • Car T Cell Therapy
  • Dendritic Cell Therapy
  • NK Cell Therapy
  • TIL Therapy
  • Others

By Indication
  • B-Cell Malignancies
  • Prostate Cancer
  • Liver Cancer
  • Renal Cell Carcinoma
  • Others

By End-Use
  • Hospitals
  • Cancer Institutes
  • Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Cellular Immunotherapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Cellular Immunotherapy Market Share by Region (Representative Graph)

Global Cellular Immunotherapy Market Share
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cellular immunotherapy market include Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences Inc. (Kite Pharma), F. Hoffmann-La Roche Ltd, Merck KGaA, GlaxoSmithKline plc., AstraZeneca, Pfizer Inc., Johnson & Johnson, Celyad, Adicet Bio Inc., Dendreon Pharmaceuticals LLC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
 
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . CELLULAR IMMUNOTHERAPY – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 Market Attractiveness Analysis By Therapy Type
           3.7.2 Market Attractiveness Analysis By Indication
           3.7.3 Market Attractiveness Analysis By End-use
           3.7.4 Market Attractiveness Analysis By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic 
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL CELLULAR IMMUNOTHERAPY MARKET ANALYSIS BY THERAPY TYPE
       6.1 Overview by Therapy Type
       6.2 Historical and Forecast Data
       6.3 Analysis by Therapy Type
       6.4 CAR T Cell Therapy Historic and Forecast Sales by Regions
       6.5 Dendritic Cell Therapy Historic and Forecast Sales by Regions
       6.6 NK Cell Therapy Historic and Forecast Sales by Regions
       6.7 TIL Therapy Historic and Forecast Sales by Regions
       6.8 Others Historic and Forecast Sales by Regions
 
7 . GLOBAL CELLULAR IMMUNOTHERAPY MARKET ANALYSIS BY INDICATION
       7.1 Overview by Indication
       7.2 Historical and Forecast Data
       7.3 Analysis by Indication
       7.4 B-cell Malignancies Historic and Forecast Sales by Regions
       7.5 Prostate Cancer Historic and Forecast Sales by Regions
       7.6 Liver Cancer Historic and Forecast Sales by Regions
       7.7 Renal Cell Carcinoma Historic and Forecast Sales by Regions
       7.8 Others Historic and Forecast Sales by Regions
 
8 . GLOBAL CELLULAR IMMUNOTHERAPY MARKET SALES ANALYSIS BY END-USE
       8.1 Overview by End-use
       8.2 Historical and Forecast Data
       8.3 Analysis by End-use
       8.4 Hospitals Historic and Forecast Sales by Regions
       8.5 Cancer Institutes Historic and Forecast Sales by Regions
       8.6 Others Historic and Forecast Sales by Regions
 
9 . GLOBAL CELLULAR IMMUNOTHERAPY MARKET SALES ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook Sales Analysis
       9.2. Introduction Sales Analysis
       9.3. North America Sales Analysis
           9.3.1. Overview, Historic and Forecast Sales Analysis
           9.3.2. North America By Segment Sales Analysis
           9.3.3. North America By Country Sales Analysis
           9.3.4. United State Sales Analysis
           9.3.5. Canada Sales Analysis
           9.3.6. Mexico Sales Analysis
       9.4. Europe Sales Analysis
           9.4.1. Overview, Historic and Forecast Sales Analysis
           9.4.2. Europe by Segment Sales Analysis
           9.4.3. Europe by Country Sales Analysis
           9.4.4. United Kingdom Sales Analysis
           9.4.5. France Sales Analysis
           9.4.6. Germany Sales Analysis
           9.4.7. Italy Sales Analysis
           9.4.8. Russia Sales Analysis
           9.4.9. Rest Of Europe Sales Analysis
       9.5. Asia Pacific Sales Analysis
           9.5.1. Overview, Historic and Forecast Sales Analysis
           9.5.2. Asia Pacific by Segment Sales Analysis
           9.5.3. Asia Pacific by Country Sales Analysis
           9.5.4. China Sales Analysis
           9.5.5. India Sales Analysis
           9.5.6. Japan Sales Analysis
           9.5.7. South Korea Sales Analysis
           9.5.8. Australia Sales Analysis
           9.5.9. Rest Of Asia Pacific Sales Analysis
       9.6. Latin America Sales Analysis
           9.6.1. Overview, Historic and Forecast Sales Analysis
           9.6.2. Latin America by Segment Sales Analysis
           9.6.3. Latin America by Country Sales Analysis
           9.6.4. Brazil Sales Analysis
           9.6.5. Argentina Sales Analysis
           9.6.6. Peru Sales Analysis
           9.6.7. Chile Sales Analysis
           9.6.8. Rest of Latin America Sales Analysis
       9.7. Middle East & Africa Sales Analysis
           9.7.1. Overview, Historic and Forecast Sales Analysis
           9.7.2. Middle East & Africa by Segment Sales Analysis
           9.7.3. Middle East & Africa by Country Sales Analysis
           9.7.4. Saudi Arabia Sales Analysis
           9.7.5. UAE Sales Analysis
           9.7.6. Israel Sales Analysis
           9.7.7. South Africa Sales Analysis
           9.7.8. Rest Of Middle East And Africa Sales Analysis
 
10 . COMPETITIVE LANDSCAPE OF THE CELLULAR IMMUNOTHERAPY COMPANIES
       10.1. Cellular Immunotherapy Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF CELLULAR IMMUNOTHERAPY INDUSTRY
       11.1. Top 10  Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Bristol-Myers Squibb Company
           11.3.1. Company Overview
           11.3.2. Company Revenue
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Novartis AG
           11.4.1. Company Overview
           11.4.2. Company Revenue
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Gilead Sciences Inc. (Kite Pharma)
           11.5.1. Company Overview
           11.5.2. Company Revenue
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. F. Hoffmann-La Roche Ltd
           11.6.1. Company Overview
           11.6.2. Company Revenue
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Merck KGaA
           11.7.1. Company Overview
           11.7.2. Company Revenue
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. GlaxoSmithKline plc.
           11.8.1. Company Overview
           11.8.2. Company Revenue
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. AstraZeneca
           11.9.1. Company Overview
           11.9.2. Company Revenue
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. Pfizer Inc.
           11.10.1. Company Overview
           11.10.2. Company Revenue
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. Johnson & Johnson
           11.11.1. Company Overview
           11.11.2. Company Revenue
           11.11.3. Products
           11.11.4. Recent Developments
       11.12. Celyad
           11.12.1. Company Overview
           11.12.2. Company Revenue
           11.12.3. Products
           11.12.4. Recent Developments
       11.13. Adicet Bio Inc.
           11.13.1. Company Overview
           11.13.2. Company Revenue
           11.13.3. Products
           11.13.4. Recent Developments
       11.14. Dendreon Pharmaceuticals LLC
           11.14.1. Company Overview
           11.14.2. Company Revenue
           11.14.3. Products
           11.14.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES
 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Therapy Type (USD MN)
  •  CAR T Cell Therapy Market Sales by Geography (USD MN)
  •  Dendritic Cell Therapy Market Sales by Geography (USD MN)
  •  NK Cell Therapy Market Sales by Geography (USD MN)
  •  TIL Therapy Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Analysis Market by Indication (USD MN)
  •  B-cell Malignancies Market Sales by Geography (USD MN)
  •  Prostate Cancer Market Sales by Geography (USD MN)
  •  Liver Cancer Market Sales by Geography (USD MN)
  •  Renal Cell Carcinoma Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Analysis by End-use (USD MN)
  •  Hospitals Market Sales by Geography (USD MN)
  •  Cancer Institutes Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Cellular Immunotherapy Market Sales by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisition
 
 LIST OF FIGURES
 
  •  Research Scope of Cellular Immunotherapy Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Cellular Immunotherapy Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Therapy Type
  •  Market Attractiveness Analysis by Indication
  •  Market Attractiveness Analysis by End-use
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Therapy Type (USD MN)
  •  CAR T Cell Therapy Market Sales by Geography (USD MN)
  •  Dendritic Cell Therapy Market Sales by Geography (USD MN)
  •  NK Cell Therapy Market Sales by Geography (USD MN)
  •  TIL Therapy Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market Analysis by Indication (USD MN)
  •  B-cell Malignancies Market Sales by Geography (USD MN)
  •  Prostate Cancer Market Sales by Geography (USD MN)
  •  Liver Cancer Market Sales by Geography (USD MN)
  •  Renal Cell Carcinoma Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market Analysis by End-use (USD MN)
  •  Hospitals Market Sales by Geography (USD MN)
  •  Cancer Institutes Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Top Company Share Analysis
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
After Sales Support
24/7 Email Support

Clients

Testimonials